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Abstract
The roles of Pax6 were investigated in the murine eye and the olfactory epithelium by analysing gene expression and distribution of
Pax6/ cells in Pax6/7 Pax6/ chimeras. It was found that between embryonic days E10.5 and E16.5 Pax6 is autonomously required
for cells to contribute fully not only to the corneal epithelium, where Pax6 is expressed at high levels, but also to the to the corneal stroma
and endothelium, where the protein is detected at very low levels. Pax6/ cells contributed only poorly to the neural retina, forming small
clumps of cells that were normally restricted to the ganglion cell layer at E16.5. Pax6/ cells in the retinal pigment epithelium could
express Trp2, a component of the pigmentation pathway, at E14.5 and a small number went on to differentiate and produce pigment at E16.5.
The segregation and near-exclusion of mutant cells from the nasal epithelium mirrored the behaviour of mutant cells in other developmental
contexts, particularly the lens, suggesting that common primary defects may be responsible for diverse Pax6-related phenotypes.
© 2003 Elsevier Science (USA). All rights reserved.
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Introduction
The transcription factor Pax6 is widely expressed
throughout murine eye development in the lens, corneal
epithelium, iris, ciliary body, all layers of the neural retina,
and the retinal pigment epithelium (RPE) (Grindley et al.,
1995; Hitchcock et al., 1996; Koroma et al., 1998; Walther
and Gruss, 1991). At E9, Pax6 is expressed in a broad
domain of the facial epithelium, subsequently becoming
restricted to the lens and nasal placodes at E10 (Grindley et
al., 1995; Li et al., 1994). In mice that are homozygous null
for Pax6, eye and olfactory system development stops at an
early stage, with the failure of lens and nasal placode for-
mation (Grindley et al., 1995; Hill et al., 1991; Hogan et al.,
1986). This creates problems for the analysis of the roles of
Pax6 in tissues such as the corneal epithelium and retina
(where the gene is normally expressed), which never form
in the mutants, and does not allow analysis of later roles during
the differentiation of the lens and olfactory epithelium.
Cre-lox tissue-specific knockouts of Pax6 in the lens
(Ashery-Padan et al., 2000) and the distal retina (Marquardt
et al., 2001) have been used to address some of these issues.
These studies showed that Pax6 is required for lens placode
formation and that knocking out Pax6 in neural retinal cells
severely restricts their potential fates.
Previously (Collinson et al., 2000; Quinn et al., 1996)
chimeras were used to overcome these problems and study
roles for Pax6 during complex tissue–tissue interactions and
in tissues that do not form in the mutants. Production of
chimeras allows fine-scale analysis of autonomy and non-
autonomy of gene function at the single cell level (Rossant
and Spence, 1998; West, 1999) and is especially useful to
study tissues where promoters that efficiently target expres-
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sion of Cre recombinase have not been identified. By mak-
ing Pax6/ 7 Pax6/ chimeras that were a mixture of
wild-type and Pax6/ cells, Quinn et al. (1996) showed
that in chimeras that were composed of less than 50%
Pax6/ cells (“low-percentage chimeras”), invaginated na-
sal epithelia were formed and eyes developed that had a
lens, two-layered retina (an inner layer that is the prospec-
tive neural retina and outer layer that will become the RPE),
and cornea. Analysis of the distribution of Pax6/ cells in
such chimeras at E12.5 showed that mutant cells could not
contribute to the nasal epithelium or the lens. Mutant cells
were present at extremely low frequency in the neural retina
and could contribute to the outer layer of the optic cup, the
presumptive RPE, but did not form pigment.
Collinson et al. (2000) showed that the near-exclusion of
mutant cells from the future lens and retina was manifest at
E9.5, and that Pax6 is required for maintenance of lens
competence and for the adhesion of the optic vesicle to the
prospective lens placode. The study did not address whether
there is an autonomous requirement for Pax6 at or before
nasal placode formation. Several other questions relating to
the fate of mutant cells during development remained, as
follows: (1) Whether Pax6 is required during differentiation
of the corneal epithelium; (2) Whether the mutant cells that
were present in the neural retina of E12.5 Pax6/ 7
Pax6/ chimeras would subsequently be eliminated, or
whether they could differentiate; (3) Whether the failure of
Pax6/ cells to produce pigment in the chimeric RPE is a
developmental block, or merely a delay?
In the present study, analyses of the distribution of
Pax6/ cells in series of Pax6/7 Pax6/ chimeras at
E9.5, E10.5, E14.5, and E16.5 were performed to address
these outstanding issues, which have important implications
for our understanding of the common roles of Pax6 in
genetic networks controlling development.
Materials and methods
Mouse stocks and production of chimeras
Mouse stocks, their maintenance, and the production of
chimeric embryos by aggregation have been described pre-
viously (Quinn et al., 1996). Two null mutations of Pax6
were used, Pax6Sey and Pax6Sey-Neu (Hill et al., 1991). Em-
bryos were obtained from a cross between pigmented (C/C)
heterozygous Pax6Sey/ males, homozygous for a reiterated
silent -globin transgene marker TgN(Hbb-b1)83Clo
(henceforth referred to as Tg) (Lo, 1986; Lo et al., 1987),
and the glucose phosphate isomerase 1-B, Gpi1b allele
(Pax6Sey/; C/C; Tg/Tg; Gpi1b/b), and superovulated,
pigmented, Gpi1b/b Pax6Sey-Neu/ females which did not
carry the transgene (Pax6Sey-Neu/; C/C; Gpi1b/b). Eight-cell
embryos were flushed from the reproductive tract at E2.5
and aggregated with eight-cell embryos from an albino,
Gpi1a/a Pax6/ wild-type cross (BALB/c  A/J)F2
(Pax6/; c/c; Gpi1a/a), not carrying the Tg transgene. After
overnight culture, chimeric embryos were transferred into
the uteri of pseudopregnant “CF1” (West and Flockhart,
1994) female mice on day 2.5 of pseudopregnancy, this
being taken as E2.5.
Chimeric embryos were dissected into cold phosphate-
buffered saline (PBS) and staged according to criteria of
forelimb development (Wanek et al., 1989). The head was
removed and fixed in 4% (w/v) paraformaldehyde (PFA)
in PBS overnight at 4°C, before processing to wax. Tail
tissue was removed for PCR genotyping, as described pre-
viously (Collinson et al., 2000). The use of two mutant
alleles of Pax6 allowed homozygous mutant chimeras
(Pax6Sey/Sey-Neu 7 Pax6/) to be distinguished from het-
erozygous chimeras (Pax6/7 Pax6Sey/ and Pax6/7
Pax6Sey-Neu/) by PCR.
Tissues from the limbs and trunk were taken for GPI1
analysis, giving a global value of the percentage of cells
derived from each aggregated eight-cell embryo in the chi-
mera. For all aggregations, the eight-cell embryo derived
from the “wild-type” mating was Gpi1a/a, and the eight-cell
embryo derived from the Pax6/Sey-Neu  Pax6Sey/ mating
was Gpi1b/b. The percentage contribution of GPI1-B was
measured by quantitative colorimetric electrophoresis (West
and Flockhart, 1994) for all resulting chimeras—those with
higher %GPI1-B are primarily composed of cells derived
from the small eye mating, and vice versa.
Histological analysis of the distribution of cells from the
Pax6Sey-Neu/  Pax6Sey/ embryo was performed by DNA
in situ hybridisation on 7-m sections using digoxigenin-
labelled -globin probe to detect the reiterated Tg transgene
(Keighren and West, 1993). After in situ hybridisation, the
percentage of transgene-positive (Tg) cells in various tis-
sues of the eye was calculated by counting the number of
Tg and Tg cells.
Primary estimates of %hybridisation-positive cells were
corrected as follows on a tissue-by-tissue basis to allow for
failure to detect the signal in some Tg cells, due to sectioning
through the nucleus. The apparent percentage of hybridisation-
positive nuclei in each tissue of (Pax6Sey-Neu/, Tg/) 
(Pax6Sey/, Tg/) embryos (nonchimeric, 100% Tg/) was
counted, and these percentages were used as correction factors
when counting the hybridisation-positive cells in the same
tissues in chimeras. Unless stated otherwise, numerical results
are summarised as mean standard error of the mean (SEM).
Statistical analysis of count data was performed using Statview
Statistical Software (Abacus Concepts Inc., CA).
In situ hybridisation for Pax6 and Trp2 expression
Digoxygenin-labelled riboprobes were transcribed from
Pax6 (Grindley et al., 1995) and Trp2 partial cDNAs using
the DIG RNA-labelling kit (SP6/T7) (Roche Diagnostics
Ltd., Lewes, UK). The Trp2 clone was a gift from Dr I.
Jackson, MRC Human Genetic Unit, Edinburgh. In situ
hybridisation was performed on 7-m semiserial sections
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(Caric´ et al., 1997). Adjacent sections were hybridised for
visualisation of the -globin transgene as described above.
Sections were lightly counterstained with hematoxylin and
examined using bright-field microscopy.
Immunohistochemical detection of Pax6
Embryos were fixed in 4% w/v paraformaldehyde, de-
hydrated, and embedded in paraffin wax. Sections measur-
ing 7 m were dewaxed and rehydrated, then boiled in 0.01
M citrate buffer, pH 6 for 20 min. After 20 min cooling,
slides were rinsed with 50 mM TBS before blocking for 30
min (blocking buffer: 20% normal rabbit serum in TBS).
Monoclonal Pax6 antibody from the Developmental Studies
Hybridoma Bank was diluted 1:50 in blocking buffer, and
sections were incubated in the primary antibody solution for
1 h at room temperature. After four 5-min washes in TBS,
secondary antibody (biotin-labelled rabbit anti-mouse
(DAKO UK Ltd.) diluted 1:200 in blocking buffer) was
added to sections for 30 min at room temperature; then
sections were rinsed in TBS four times for 5 min. The
avidin/biotin ABC solution (DAKO UK Ltd.) was added to
sections, followed by three 5-min washes in TBS. The
sections were then stained with diaminobenzidine (Sigma,
UK) for 25 min, rinsed in water, dehydrated, and mounted.
Results
Pax6 is required cell-autonomously for development of all
layers of the cornea
Immunostaining was performed on sections of paraffin-
embedded eye sections at E16.5. Strong expression of Pax6
occurred in the lens and corneal epithelia, and in all layers
of the retina, but only very weak labelling was seen in the
neural crest derived mesenchymal cells of the corneal
stroma and iridocorneal angle (Fig. 1). The pattern of stain-
ing was identical to that described recently by Baulmann et
al. (2002). Using both immunohistochemistry and X-Gal
analysis of the Pax6LacZ mouse, Baulmann et al. found weak
Pax6 labelling at E19 in mesenchymal cell nuclei around the
iridocorneal angle in the corneal stroma and endothelium,
iris stroma, and prospective trabecular meshwork.
To investigate whether Pax6 might have autonomous
roles during development of the cornea, 22 E16.5 chimeras
were produced. Genotypic analysis showed that 6 chimeras
were of the Pax6/ 7 Pax6Sey/Sey-Neu combination (i.e., a
mixture of Tg Pax6/ and Tg Pax6Sey/Sey-Neu cells—
henceforth termed Pax6/7 Pax6/) and 10 were either
Pax6/ 7 Pax6Sey-Neu/ or Pax6/ 7 Pax6Sey/. Six
were Pax6/7 Pax6/ “control” chimeras composed of
Tg Pax6/ and Tg Pax6/ cells. As described under
Materials and methods, the ratio of GPI1-A and GPI1-B
allozymes in the trunk of each embryo was determined by
quantitative electrophoresis: %GPI1-B was taken as a
global estimate of the percentage of cells derived from the
Pax6Sey-Neu/  Pax6Sey/ eight-cell embryo that was
present in the E16.5 chimera. The distribution of these cells
in the cornea was identified histologically by DNA in situ
hybridisation on wax sections using a digoxigenin-labelled
probe which recognised the -globin transgene Tg carried
homozygously by the male Pax6Sey/ stud mice. Only “low-
percentage” chimeras with 55% mutant cells were used for
the analysis, since those with higher proportions of mutant
cells lacked lenses and properly differentiated retinas, hence
making unequivocal identification of the cornea impossible.
The contribution of Tg, Pax6/ cells to the corneal
epithelium (Ep), endothelium (En), and stroma (S) of
Pax6/ 7 Pax6/ chimeras was compared to the distri-
bution of Tg wild-type cells in control chimeras. For all
Fig. 1. Expression of Pax6 in the E16.5 eye. (A) Immunohistochemical
staining of a Pax6/7 Pax6/ control chimera showing strong staining
in the lens and corneal epithelia, the neural retina and distal RPE, and both
epithelial layers of the iris. Weak staining is detected in the iris stroma, and
cells of the corneal stroma. A negative (no primary antibody) control of an
adjacent section (B), stained simultaneously with (A), shows nonspecific
staining at the apical surface of the endothelium only, and no nuclear
staining in any tissue. Key: le, lens; e, corneal epithelium; s, corneal
stroma; en, corneal endotheium; i, iris/ciliary body.
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chimeric eyes, the %Tg cells in the three layers of the
cornea was calculated separately and divided by the
%GPI1-B (B) of the chimera. These data are presented in
full in Table 1 and summarised in Fig. 2. The mean Ep/B
ratio for Pax6/ 7 Pax6/ chimeras (0.009  0.003
SEM; n  8 eyes) was significantly lower than Ep/B of
Pax6/ 7 Pax6/ controls (0.589  0.064; n  10;
t-test: P  0.0001) (Fig. 2A). Hence Pax6/ cells were
severely underrepresented in the corneal epithelium, a tissue
in which high levels of Pax6 protein are detected. In com-
parison to control chimeras, Pax6/, Tg cells were also
underrepresented in the corneal stroma and endothelium,
albeit less dramatically. The mean S/B ratio for the stroma
of Pax6/ 7 Pax6/ chimeras was 0.192  0.046, n 
8, which is significantly less than the mean S/B ratio for
Pax6/ 7 Pax6/ chimeras (0.601  0.071, n  10;
t-test P  0.001) (Fig. 2B). In the endothelium, the mean
En/B ratio for Pax6/7 Pax6/ chimeras was 0.139 
0.044, n  8, significantly less than the mean En/B ratio for
Pax6/ 7 Pax6/ chimeras (0.894  0.113, n  10;
t-test, P  0.0001) (Fig. 2C). Thus, there is an autonomous
requirement for functional Pax6 for full and normal contri-
bution of cells to all layers of the cornea. This had not
previously been demonstrated. The effect is most pronounced
in the tissue with highest levels of Pax6 expression.
In chimeras studied previously at E9.5 (Collinson et al.,
2000), it was found that Pax6/ cells in Pax6/ 7
Pax6/ chimeras were eliminated from an area of the
facial epithelium wider than the lens placode. This poten-
tially included, at least in part, the anlage fated to become
the corneal epithelium. It was therefore possible that the
absence of mutant cells from the E16.5 chimeric corneal
epithelium was a result of a much earlier elimination at E9.5
and did not represent a specific failure of mutant cells to
contribute to differentiating corneal epithelium. The contri-
bution of Pax6/ cells to the corneal epithelium overlying
the invaginating lens in a series of E10.5 Pax6/ 7
Pax6/ chimeras was therefore investigated. By counting
the presence of Tg, Pax6/ cells in the prospective cor-
neal epithelium of each eye at E10.5 (Ep) and dividing by
the %GPI1-B for that chimera, it was found that mutant
cells had already repopulated the prospective corneal epi-
thelium (Ep/B  0.676  0.123; n  11). As an approxi-
mate comparison, Tg Pax6/ cells were counted in the
prospective corneas of three Pax6/ 7 Pax6/ E10.5
chimeras, giving a mean Ep/B ratio of 0.921  0.210.
Qualitatively, Pax6/ cells were also present in the corneal
epithelium of E12.5 chimeras of Quinn et al. (1996).
It is concluded that Pax6/ cells are present in signif-
icant numbers in the corneal epithelia of E10.5 Pax6/ 7
Table 1
Contribution of cells to different layers of the E16.5 cornea
Eye B cornEp% Ep Ep/B cornS% S S/B cornEn% En En/B
(i) Control chimeras
MC268L 41.67 77/802 9.601 14.402 0.346 182/2153 8.453 12.680 0.304 64/292 21.917 28.790 0.691
MC268R 41.67 160/1224 13.072 19.608 0.471 465/2828 16.443 24.664 0.592 66/312 21.150 27.780 0.667
MC232L 48.67 300/1090 27.523 41.284 0.848 759/3017 25.157 37.736 0.775 101/349 28.940 38.010 0.781
MC232R 48.67 241/955 25.236 37.853 0.778 611/2587 23.618 35.427 0.728 276/581 47.504 63.930 1.314
MC228L 31.01 69/676 10.207 15.311 0.494 137/1398 9.800 14.700 0.474 106/432 24.537 33.030 1.065
MC228R 31.01 86/908 9.471 14.207 0.458 208/2422 8.588 12.882 0.415 116/481 24.116 32.450 1.047
MC328L 12.00 17/470 3.617 5.426 0.452 39/1003 3.888 5.833 0.486 7/196 3.571 4.805 0.400
MC328R 12.00 13/381 3.412 5.188 0.432 37/1030 3.592 5.388 0.449 20/581 3.442 4.633 0.386
MC310L 50.00 84/275 30.545 45.818 0.916 345/948 35.865 53.798 1.076 251/529 47.448 63.840 1.277
MC310R 50.00 89/384 23.177 34.766 0.695 262/1142 23.555 35.333 0.707 262/536 48.881 65.780 1.316
Mean 0.589 0.601 0.894
SEM 0.064 0.071 0.113
(ii) Homozygous mutant chimeras
A/M5L 21.83 2/1003 0.181 0.271 0.012 28/2147 1.304 1.946 0.089 8/402 1.990 2.678 0.123
A/M5R 21.83 1/1063 0.094 0.141 0.006 63/2517 2.503 3.754 0.172 9/417 2.158 2.904 0.133
A/M11L 39.80 2/757 0.264 0.396 0.010 110/1388 7.925 11.887 0.299 8/281 2.856 3.844 0.097
MC230L 19.33 2/506 0.395 0.592 0.031 51/1666 3.061 4.592 0.238 5/300 1.167 1.571 0.081
MC230R 19.33 0/585 0.000 0.000 0.000 27/2228 1.212 1.809 0.094 1/449 0.223 0.300 0.016
MC272R 33.73 1/621 0.161 0.241 0.007 97/1985 4.887 7.330 0.217 30/348 8.621 11.602 0.343
MC272L 33.73 1/568 0.176 0.263 0.008 178/1897 9.383 14.005 0.415 29/364 7.967 10.722 0.318
MC270L 5.53 0/1900  0.000 0.000 0.000 2/4940 0.041 0.061 0.011 1/1140 0.001 0.001 0.000
Mean 0.009 0.192 0.139
SEM 0.003 0.046 0.044
Note. B%GPIl-B of chimera; SEM standard error of the mean. cornEp%, cornS%, cornEn% number of Tg cells divided by number of cells scored
and expressed as a percentage in corneal epithelium, stroma, and endothelium, respectively. Ep, S, En  cornEp%, cornS%, and cornEn%, respectively,
multiplied by correction factors described under Materials and methods.
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Pax6/ chimeras and are still readily detectable at E12.5.
Their absence at E16.5 therefore represents a specific elim-
ination that does not result solely from the proven require-
ment for Pax6 in the E9.5 facial epithelium. Pax6 is auton-
omously required for normal contribution to the corneal
epithelium between E10.5 and E16.5.
Pax6 is required for normal retinal development
In E16.5 Pax6/7 Pax6/ and Pax6/7 Pax6/
chimeras, Pax6/ or Pax6/ cells, respectively, were
detected in all layers of the retina, forming clonally related
stripes as reported previously (Fig. 3A; Collinson et al.,
2001). Pax6/ Tg cells were detected at very low fre-
quencies in the retinas of Pax6/7 Pax6/ chimeras, as
aggregations of up to 100 cells almost exclusively in the
developing ganglion cell layer (Fig. 3B and C). In three
retinas small groups of up to 10 Pax6/ Tg cells were
seen in sections of the undifferentiated inner/outer nuclear
layer (Fig. 3D). Stripes of Pax6/ Tg cells spanning the
thickness of the retina were never observed. The underrep-
resentation Pax6/ cells in the E16.5 retina and their
abnormal clonal arrangement demonstrate that Pax6 is re-
quired for normal contribution of cells to the retina during
development. Because of the very small proportions of
Pax6/ cells in the retinas at this age, it was not possible to
determine, by the use of molecular markers, whether the mu-
tant cells were differentiating appropriately for their location.
Absence of Pax6 delays but does not prevent
pigmentation of the RPE
In the outer layer of the optic cup (the prospective RPE)
of the E16.5 chimeras, Pax6/ cells, although underrepre-
sented, were present at higher frequency than in the neural
retina. In most cases (five of six retinas that were examined
serially), some of these mutant cells had produced pigment,
showing that Pax6 is not absolutely required for melanin
production in the RPE (Fig. 3E). In comparison with the
E12.5 chimeras produced by Quinn et al. (1996), in which
mutant cells did not produce pigment, it can now be con-
cluded that absence of Pax6 delays the full differentiation of
RPE cells but does not prevent it.
To investigate the molecular basis of pigmentation in the
mutant cells, in situ hybridisation was performed on E14.5
chimeric tissues, prior to the appearance of pigment, using
probes against Pax6 and Trp2, an early marker of the RPE
pigmentation pathway (Fig. 3F–K). In control E14.5 eyes, it
was confirmed that Trp2 expression is confined to the RPE
and scattered melanocytes in the extraocular mesenchyme
(Fig. 3F), whereas Pax6 is expressed in all layers of the
retina, and the corneal and lens epithelia (Fig. 3G and K).
Trp2 expression was detectable in all Pax6/ cells in the
outer layer (the presumptive RPE) of the bilayered optic cup in
E14.5 Pax6/7 Pax6/ chimeras (Fig. 3H, I, and J). This
demonstrated that absence of Pax6 does not preclude the ex-
pression of genes in the normal RPE pigmentation pathway.
Early roles for Pax6 during the differentiation of the
olfactory epithelium
During normal development, nasal placodes are induced
in the facial ectoderm at E9.5, which subsequently involute
to form the olfactory epithelia. Grindley et al. (1995) dem-
onstrated that Pax6 is expressed throughout this process and
that nasal development ceases at E9.5 in the mutant mice.
They could, however, not distinguish whether this was an
autonomous failure of the nasal epithelium or whether it
represented a failure of exogenous inductive signals neces-
sary for nasal placode formation.
To address this question, the prospective nasal epithelia
of E9.5 Pax6/7 Pax6/, Tg chimeras and Pax6/7
Pax6/, Tg chimeras were compared. At E9.5, a broad
area of thickened epithelium includes the prospective nasal
placode, but the placode itself is not yet a discrete recogni-
sable structure (J.M.C., personal observation). The propor-
tion of Tg cells in the nasal epithelium (expressed as a
Fig. 2. Underrepresentation of Pax6/ cells in (A) the E16.5 corneal
epithelium, (B) corneal stroma, and (C) corneal endothelium. For each
chimeric eye, the percentage of Tg cells in the corneal epithelium, Ep,
stroma, S, and endothelium, En, was divided by global %GPI1-B, B, for
that chimera. Mean values  standard errors are plotted for 10 control
Pax6/ 7 Pax6/ Tg eyes (white columns) and 8 Pax6/ 7
Pax6/ Tg eyes (black columns). Small values of Ep/B, S/B, and En/B
indicate that Pax6/ cells are underrepresented in all layers of the cornea,
present in proportions that do not reflect the global composition of the chimera.
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percentage, N) was counted for each E9.5 chimera produced
in a previous study (Collinson et al., 2000) and divided by
the contribution of Tg cells to the ectoderm round the
dorsal side of the head that does not express Pax6 (H). The
ratio N/H was calculated as an indication of any underrep-
resentation of Tg cells in the prospective preplacodal nasal
epithelium at E9.5 compared to the nonspecialised head
ectoderm.
For Pax6/ 7 Pax6/ chimeras N/H  1.032 
0.080, n  8, confirming that Pax6/, Tg cells are
equally distributed between the nasal epithelium and other
regions of the head. In contrast, for Pax6/ 7 Pax6/
chimeras, N/H  0.358  0.052, n  13. These values are
very significantly different (t-test: P  0.00001). This dem-
onstrates that there is an autonomous requirement for Pax6
in the preplacodal nasal epithelium, such that homozygous
mutant cells cannot fully contribute. The elimination of
mutant cells is not absolute, however, and not as complete
as is seen in the prospective lens placode at this stage:
calculation of the %Tg cells in the prospective lens pla-
code of low percentage Pax6/7 Pax6/ Tg chimeras
(L) (data in Collinson et al., 2000) gave mean L/H  0.187
Fig. 3. Contribution of Pax6/ cells and expression of genetic markers in the chimeric retina at E16.5 (A–E) and E14.5 (F–K). (A) Normal distribution of
Tg Pax6/ cells revealed by the presence of brown dots in nuclei in an E16.5 control chimera, after DNA–DNA in situ hybridisation using a DIG-labelled
-globin probe against the Tg transgene. Stripes of clonally related cells span all layers of the neural retina. (B, C) Abnormal clumps of Tg Pax6/ cells
in the ganglion cell layer of a chimera. Stripes of cells equivalent to that seen in (A) were never observed. (D) A small group of Pax6/ cells in the
undifferentiated nuclear cell layer of a Pax6/ 7 Pax6/ chimera. (E) Pigmented Pax6/ cells (arrowheads) in the RPE of a Pax6/ 7 Pax6/
chimera. (F) In situ hybridisation showing Trp2 expression in the prospective RPE of a Pax6/7 Pax6/ chimeric control E14.5 eye. (G) Pax6 expression
in an adjacent section to (F). (H) Trp2 expression in the retina of a E14.5 Pax6/ 7 Pax6/ chimera composed of 83% Pax6/ cells. Unlike low
percentage chimeras, no lens is present and the retina is abnormally folded; in this section, the convoluted retina is composed of two bilayered loops of tissue
with a thick inner layer (presumptive neural retina) and a thinner outer layer that expresses Trp2 (presumptive RPE). (I) Enlarged section of H, showing Trp2
expression in prospective RPE of lower loop. (J) In situ hybridisation for the -globin transgene to reveal the location of Pax6/ cells on an adjacent section
to (I) shows that the lower loop of retina in H is largely composed of mutant cells. The area of prospective RPE between the arrowheads, shown in (I) to
be Trp2-positive, is composed almost exclusively of mutant cells. The upper loop of retinal tissue (top right) is exclusively composed of wild-type cells. Both
mutant and wild-type RPE cells in the chimeras therefore express Trp2. (K) Pax6 expression in an adjacent section to (I) and (J) shows that the mutant Pax6
mRNA is present Pax6/ RPE, but the levels of expression are patchy. Scale bars represent (A) 40 m; (D) 10 m; (F) 100 m.
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 0.070, n  8. We suggest that there is a decrease in the
rate of proliferation, or an increase in apoptosis, or perhaps
movement of mutant cells out of the Pax6-expressing lens
and nasal regions, but that these processes are more pro-
nounced, or start earlier, in the lens. A new series of exper-
iments will be needed to examine these possibilities.
Exclusion of Pax6/ cells from invaginating lens and
nasal placodes
To investigate the fate of the small proportion of mutant
cells that were retained in the prospective nasal epithelium
at E9.5, the nasal epithelia of a series of 14 control and 10
Pax6/ 7 Pax6/, E10.5 chimeras were examined. In
Pax6/ 7 Pax6/, Tg chimeras, Tg cells were dis-
tributed randomly throughout the invaginating nasal pla-
code as expected (Fig. 4A). In contrast, the invaginating
epithelium of Pax6/7 Pax6/ chimeras was composed
almost entirely of wild-type cells. In most cases, ectopic
buds composed of entirely Pax6/ cells were detected,
projecting into the mesenchyme but contiguous with the
nasal epithelium (Fig. 4B). Similar ectopic buds were never
seen in control chimeras. These ectopic buds were inter-
preted as representing mutant cells that were being physi-
cally excluded from the differentiating nasal epithelium.
That no such structures were seen at E12.5 by Quinn et al.
(1996) suggests that they are short-lived and may be elim-
inated by apoptosis. Hence there are at least two stages
(preplacodal and during invagination of the placode) at
which Pax6 is required for normal development and differ-
entiation of the nasal epithelium.
Collinson et al. (2000) demonstrated that homozygous
mutant cells were almost eliminated in a region of facial
epithelium that was wider than, but included, the prospec-
tive lens placode. The present study shows that the region of
near-exclusion also includes the prospective nasal placode,
which may fall within the same domain of facial Pax6
expression (Grindley et al., 1995). To investigate the fate of
Pax6/ cells that are retained in the prospective lens pla-
code at E9.5, the lenses of the E10.5 chimeras were studied.
In line with the more complete exclusion of mutant cells
from the E9.5 lens than from the nasal region, the invaginating
lenses of E10.5 chimeras were almost exclusively wild-type. In
two chimeras, a small rosette of mutant cells was found adja-
cent to the posterior of the lens (Fig. 4C). Because this was
never seen in control chimeras or wild-type embryos, we
postulate that these mutant rosettes may also be the result of
physical exclusion from the invaginating placode.
Discussion
Roles of Pax6 in the cornea
Chimeric studies have now demonstrated autonomous
roles for Pax6 in all eye tissues where it is expressed, at
Fig. 4. Physical elimination of Pax6/ cells from the invaginating nasal
epithelium and lens. (A) Nasal epithelium of an E10.5 control chimera, after
DNA–DNA in situ hybridisation to detect the Tg transgene. Tg Pax6/ cells
(brown dots in nuclei) are distributed randomly throughout the olfactory
epithelium. (B) Distribution of Tg Pax6/ cells in the olfactory epithelium
of an equivalent E10.5 Pax6/ 7 Pax6/ chimera. Mutant cells are not
present in the normal invaginating structure, but are confined to vesicle-like
outgrowths (arrowheads). The exogenous structures are partly contiguous with
the olfactory epithelium (a stalk of tissue can be seen to connect the right-hand
ectopic bud to the olfactory epithelium). (C) The lens vesicle of an E10.5
Pax6/ 7 Pax6/ chimera. The lens is entirely wild-type apart from a
small bleb of Pax6/ cells (arrowhead) projecting from the posterior edge.
Note that this bleb of cells is contained within the basement membrane of the
lens vesicle. Scale bar represents 20 m.
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several developmental stages, while suggesting that Pax6
dosage in the lens is most critical for normal eye develop-
ment (Collinson et al., 2000, 2001; Quinn et al., 1996; this
study). The chimeric studies are summarised in Table 2.
Multiple abnormalities in the corneas of heterozygous
Pax6/LacZ and Pax6/Sey-Neu mice have been reported
(Baulmann et al., 2002; Ramaesh et al., 2003). From E18.5
the corneal epithelium is thinner than wild-type, and the
stroma is hypercellular, with an irregular laminar arrange-
ment and other defects. These phenotypes become more
severe with age and are hypothesised to reflect failure of
corneal maintenance in response to environmental injury. In
a previous study no underrepresentation of Pax6/ cells
was found in the corneas of E16.5 Pax6/ 7 Pax6/
chimeras (Collinson et al., 2001), suggesting that the defects
in the heterozygous cornea are not a result of cell-autono-
mous failure of primary development.
In this study, it was shown that homozygous Pax6/
cells do not contribute to the corneal epithelium of E16.5
Pax6/ 7 Pax6/ chimeras, even though they were
present at E10.5 and E12.5. Functional Pax6 is therefore an
absolute requirement of normal participation in the early
development of the corneal epithelium, a tissue in which
Pax6 expression levels are high.
More surprisingly, functional Pax6 was also required for
full participation in the development of the corneal stroma
and endothelium. Pax6 expression in these neural crest
derived tissues has recently been detected in mid-late fetal
stages (using two different antibodies and LacZ staining)
and is very much weaker that that seen in other eye tissues
(Fig. 1; Baulmann et al., 2002). However, Pax6 is expressed
broadly in the forebrain from E8 and the forebrain-derived
neural crest cells that populate the periocular mesenchyme
(Trainor and Tam, 1995) may retain Pax6 expression at
earlier stages. Defects in migration of cranial neural crest
cells in Pax6/ embryos have been demonstrated, al-
though the evidence suggested that these were a nonauto-
nomous consequence of the failure of signaling from the
frontonasal ectoderm (Matsuo et al., 1993; Osumi-Ya-
mashita et al., 1997). Our data suggest that these failures are
at least in part cell-autonomous and are the first proven
autonomous roles for Pax6 in a neural crest-derived tissue.
Roles of Pax6 in the retina
We found that Pax6/ cells could, albeit in small num-
bers, contribute to the ganglion cell layer at E16.5 and were
also detectable in the nuclear layers. Mutant cells in the
ganglion layer appeared abnormal, forming tight clusters or
having a vesicular appearance, and it is perhaps unlikely
that they were differentiating correctly. The contribution to
the ganglion cell layer is unexpected in light of a comple-
mentary study in which Pax6 was inactivated in the distal
retina during early embryogenesis (Marquardt et al., 2001).
In that study, Pax6/ cells differentiated as amacrine cells
but could not form any other retinal cell type. The most
likely explanation for the discrepancy between the two
studies is that in the Marquardt et al. Cre-lox system, Pax6
was not inactivated until E10.5, whereas cells in our chi-
meras have never had functional Pax6. Generation of retinal
cells occurs in chronological sequence, with ganglion and
horizontal cells appearing first, followed by amacrine and
other cell types (Young, 1985). Given the stepwise and
progressive nature of retinal development from early em-
bryogenesis, it is perhaps possible that the Pax6/ cells in
our chimeras develop cell-surface characteristics that are
different from those cells that lose their Pax6 expression at
E10.5. The cells in our study may represent a more imma-
ture stage of retinal development, lagging any normally
differentiating cell type but most closely resembling the
earliest born ganglion cells. Alternatively, because dis-
placed amacrine cells are a normal constituent of the mouse
ganglion cell layer (Jeon et al., 1998), it is equally possible
that mutant cells seen in the chimeric retinas may be ama-
Table 2
Summary of roles of Pax6 in the eye and nasal epithelium at different developmental stages, determined from studies of chimeras
Stage Eye tissues studied Roles of Pax6 References
E9.5 Optic vesicle, lens placode, nasal epithelium Maintenance of placodal competence. Collinson et al., 2000; this study.
Adhesion of optic vesicle to lens placode.
Proximodistal specification of optic vesicle.
E10.5 Lens, nasal epithelium, corneal anlage Required for contribution to invaginating lens and
nasal placodes. Dosage effects responsible for
failure of heterozygote cells to contribute fully to
lens placode.
Collinson et al., 2001; this study.
E12.5 Lens, optic cup, cornea, nasal epithelium Controls cell-surface properties of neural retina.
Required for contribution to lens and nasal epithelia.
Quinn et al., 1996; Collinson et
al., 2001; this study.
Required for normal pigmentation of RPE.
E14.5 Lens, retina Not required for molecular specification of RPE. This study.
E16.5 Lens, cornea, retina, iris Correct Pax6 dosage required for lens to organise
anterior segment.
Collinson et al., 2001; this study.
Required for development of all layers of cornea.
Retinal cell development.
Normal pigmentation of RPE.
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crine-like cells that are stranded in an ectopic retinal loca-
tion.
In the RPE, the presence of a small proportion of pig-
mented Pax6/ cells showed that absence of functional
Pax6 delays differentiation but does not always prevent it.
Because both the alleles of Pax6 used in this study, Pax6Sey
and Pax6Sey-Neu, are point mutations, the possibility was
considered that the pigmented cells in the RPE were the
result of rare somatic back-mutations that restored function-
ality to one of the alleles. This hypothesis cannot be for-
mally eliminated; however, we believe it to be extremely
unlikely. Pax6/ cells (Tg) are heavily underrepresented
in the RPE, so back-mutation would have to be very com-
mon to produce pigmented cells in five of six serially
examined RPEs. This frequency would be greater than that
reported for the dilute mutation, which is caused by a viral
insertion and produced only 1 somatic and 10 germ-line
reversions among more than a million mice (Seperack et al.,
1988). It would be even greater than the reversion rate of the
laacZ transgene, which was designed as an unstable trans-
gene for use as a lineage marker and reverted by random
intragenic recombination to form 128 lacZ clones in the
brains of 1200 postnatal mice (Mathis et al., 1997). Also, if
Pax6Sey or Pax6Sey-Neu back-mutated to wild-type Pax6 at
such a high frequency to produce revertant clones in five of
six RPEs, we would expect at least occasional instances of
back-mutation in the neural retina of Pax6/ 7 Pax6/
chimeras to produce thin clonal stripes of Tg cells con-
tributing to and differentiating appropriately within one or
more layers of this epithelium. Such an event has never been
observed nor have we ever seen unexpected contributions of
homozygous mutant Tg cells to tissues such as the lens or
corneal epithelium that might be explained by back-muta-
tion during early embryogenesis. Furthermore, it was shown
that Pax6/ cells in the presumptive RPE of E14.5
Pax6/7 Pax6/ chimeras express the early pigmenta-
tion marker, Trp2, showing that the differentiation pathway
is underway in too many cells to be explained by back-
mutation.
Roles for Pax6 in the prospective lens and nasal epithelia
Collinson et al. (2000) showed that Pax6 was required in
the preplacodal lens epithelium, and Ashery-Padan et al.
(2000) demonstrated a requirement at lens placode induc-
tion. The present study has extended these results to show
that functional Pax6 is required autonomously for full con-
tribution of cells to an area of the facial epithelium that
includes the prospective nasal placode and is then abso-
lutely required during the early stages of differentiation of
the invaginating olfactory epithelium and lens placode. This
pattern of multiple roles during the differentiation of a
single tissue is characteristic of Pax6 (Cvekl and Piatigor-
sky, 1996) and is qualitatively identical in the lens and nasal
placodes.
The developmental process of lens induction is perhaps
best understood in Xenopus, where a “lens-competent” an-
terior region of early epithelium becomes progressively
biased and then determined to form the lens by a series of
inductive interactions (Grainger et al., 1988; Grainger,
1992). The area of the face that is competent to form a lens
is proportionately large, and many of the lens-competent
cells will not subsequently participate in lens placode for-
mation. Experiments performed in mouse and chicken sug-
gest that similar processes of progressive induction of a
subset of lens-competent cells occur in these species (Bara-
banov and Fedtsova, 1982; Enwright and Grainger, 1999;
Piatigorsky, 1981). The domain of Pax6 expression in the
facial epithelium at E8.5–9 is extensive and, at least in the
mouse, appears to overlap both the prospective lens and the
nasal placodes (Grindley et al., 1995). In the case of the
lens, the domain of Pax6 expression has been implicated in
defining a region of lens-competence (Li et al., 1994), and
our previous study (Collinson et al., 2000) provided evi-
dence for this assertion. Hogan et al. (1986) first suggested
that a common role for Pax6 in lens and olfactory placodes
might underlie their failure in Pax6/ mutants. Because
the expression domain of Pax6 at E8.5–E9 may encompass
both the prospective lens and the nasal placodes, it would
now be tempting to speculate that Pax6 expression in the
face defines a less specific region of “placode-forming com-
petence.” The loss of Pax6/ cells from the preplacodal or
early-placodal nasal epithelium demonstrated in this study
is evidence that Pax6 is required for maintaining the tissue-
competence that mediates nasal placode formation, and
hence, that Pax6 is indeed required to maintain the “pla-
codal competence” within the facial epithelium.
Segregation of Pax6 mutant cells from wild-type in chi-
meras was seen again in this study as it has been in all our
previous and current studies in the eye and brain (Collinson
et al., 2000, 2001; Pratt et al., 2002; Quinn et al., 1996;
Talamillo et al., 2003). This is a predicted consequence of
the control of downstream cell-surface molecules by Pax6
(Duncan et al., 2000; Stoykova et al., 1997). The apparent
physical exclusion of mutant cells from both the invaginat-
ing nasal and, sometimes, the lens placodes at E10.5 seen in
this study argues that Pax6 may have similar roles in these
two structures, possibly via the control of the same cell-
surface molecules. More E10.5 chimeric eyes will be
needed to confirm this hypothesis. We conceptualise a
model in which the common functions for Pax6 in the
facial sensory region maintain the competence to form
lens and nasal placodes and then control the cell-surface
properties that mediate their morphogenesis. The very
different fates of the nasal and lens placodes are presum-
ably a consequence of lens and nasal-specific genes that
are coexpressed with Pax6 as a result of the different
inductive influences to which they are exposed. This
model is consistent with hypothesised ancestral roles for
Pax6 as a mediator of sensory organ formation at the
anterior of the head.
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